Histoplasmosis: A clinical and laboratory update

Clinical Microbiology Reviews

Volumn 20, Issue 1, 2007, Pages 115-132

  Kauffman, Carol A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; METHYLPREDNISOLONE; POSACONAZOLE; PREDNISONE; PYRROLE DERIVATIVE; VORICONAZOLE;

ADULT RESPIRATORY DISTRESS SYNDROME; CARDIOVASCULAR INFECTION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG INDICATION; DRUG TOXICITY; DRUG USE; ENDOCARDITIS; FUNGAL DETECTION; FUNGUS CULTURE; FUNGUS TRANSMISSION; HISTOPATHOLOGY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HOST RESISTANCE; HUMAN; IMMUNOASSAY; MEDIASTINITIS; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; REVIEW; SEPSIS; SKIN TEST; SYMPTOM; THORAX RADIOGRAPHY; URINALYSIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; ENDOCARDITIS; HISTOPLASMOSIS; HUMANS; LUNG DISEASES, FUNGAL; MEDIASTINITIS;

AJELLOMYCES; AJELLOMYCES CAPSULATUS;

EID: 33846535287     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00027-06     Document Type: Review

References (169)

1. Bamberger, D. M. 1999. Successful treatment of multiple cerebral histoplasmomas with itraconazole. Clin. Infect. Dis. 28:915-916.
2. Bauman, D. S., and C. D. Smith. 1975. Comparison of immunodiffusion and complement fixation tests in the diagnosis of histoplasmosis. J. Clin. Microbiol. 2:77-80.
3. Bhatti, S., L. Vilenski, R. Tight, and R. A. Smego, Jr. 2004. Histoplasma endocarditis: clinical and mycologic features and outcomes. J. Infect. 51:2-9.
4. Bialek, R., F. Ernst, K. Dietz, L. K. Najvar, J. Knobloch, J. R. Graybill, and G. Schaumburg-Lever. 2002. Comparison of staining methods and a nested PCR assay to detect Histoplasma capsulatum in tissue sections. Am. J. Clin. Pathol. 117:597-603.
5. Bracca, A., M. E. Tosello, J. E. Girardini, S. L. Amigot, C. Gomez, and E. Serra. 2003. Molecular detection of Histoplasma capsulatum var. capsulatum in human clinical samples. J. Clin. Microbiol. 41:1753-1755.
6. Bradsher, R. W., C. G. Wickre, A. M. Savage, W. E. Harston, and R. H. Alford. 1980. Histoplasma capsulatum endocarditis cured by amphotericin B combined with surgery. Chest 78:791-795.
7. Brandt, M. E., D. Gaunt, N. Iqbal, S. McClinton, S. Hambleton, and L. Sigler. 2005. False-positive Histoplasma capsulatum Gen-Probe chemiluminescent test result caused by a Chrysosporium species. J. Clin. Microbiol. 43:1456-1458.
8. Brodsky, A. L., M. B. Gregg, L. Kaufman, and G. F. Mallison. 1973. Outbreak of histoplasmosis associated with the 1970 Earth Day activities. Am. J. Med. Sci. 54:333-342.
9. Bullock, W. E., R. P. Artz, D. Bhathena, and H. S. K. Tung. 1979. Histoplasmosis: association with circulating immune complexes, eosinophilia, and mesangiopathic glomerulonephritis. Arch. Intern. Med. 139:700-702.
10. Burke, D. G., S. N. Emancipator, M. C. Smith, and R. A. Salata. 1997. Histoplasmosis and kidney disease in patients with AIDS. Clin. Infect. Dis. 25:281-284.
11. Cano, M., and R. A. Hajjeh. 2001. The epidemiology of histoplasmosis: a review. Semin. Respir. Infect. 16:109-118.
12. Christie, A., and J. C. Peterson. 1946. Histoplasmin sensitivity. J. Pediatr. 29:417-432.
13. Clark, B., R. Foster, A. Tunbridge, and S. Green. 2005. A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole. J. Infect. 51:177-180.
14. Connolly, P. J., J. Wheat, C. Schnizlein-Bick, M. Durkin, S. Kohler, M. Smedema, J. Goldberg, E. Brizendine, and D. Loebenberg. 1999. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice. Antimicrob. Agents Chemother. 43:322-328.
15. Connolly, P. J., L. J. Wheat, C. Schnizlein-Bick, M. Durkin, S. Kohler, M. Smedema, J. Goldberg, E. Brizendine, and D. Loebenberg. 2000. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob. Agents Chemother. 44:2604-2608.
16. Corcoran, G. R., H. Al-Abdely, C. D. Flanders, J. Geimer, and T. F. Patterson. 1997. Markedly elevated serum lactate dehydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS. Clin. Infect. Dis. 24:942-944.
17. Couppie, P., M. Sobesky, C. Aznar, S. Bichat, E. Clyti, F. Bissuel, M. El Guedj, F. Alvarez, M. Demar, D. Louvel, R. Pradinaud, and B. Carme. 2004. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin. Infect. Dis. 38:134-138.
18. Crum, N. F., E. R. Lederman, and M. R. Wallace. 2005. Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore) 84:291-302.
19. Darling, S. T. 1906. A protozoan general infection producing pseudotubercles in the lungs and focal necroses in the liver, spleen, and lymph nodes. JAMA 46:1283-1285.
20. Darouiche, R. O., R. M. Cadle, G. J. Zenon, M. F. Weinert, R. J. Hamill, and M. D. Lidsky. 1992. Articular histoplasmosis. J. Rheumatol. 19:1991-1993.
21. Davies, S. F., M. Khan, and G. A. Sarosi. 1978. Disseminated histoplasmosis in immunologically suppressed patients. Am. J. Med. 64:94-100.
22. Davis, A., D. Pierson, and J. E. Loyd. 2001. Mediastinal fibrosis. Semin. Respir. Infect. 16:119-130.
23. Deepe, G. S., Jr. 1988. Protective immunity in murine histoplasmosis: functional comparison of adoptively transferred T-cell clones and splenic T cells. Infect. Immun. 56:2350-2355.
24. de Matos Guedes, H. L., A. J. Guimarães, M. M. Muniz, C. V. Pizzini, A. J. Hamilton, J. M. Peralta, G. S. Deepe, Jr., and R. M. Zancopé-Oliveira. 2003. PCR assay for identification of Histoplasma capsulatum based on the nucleotide sequence of the M antigen. J. Clin. Microbiol. 41:535-539.
25. De Monbreun, W. A. 1934. Cultivation and cultural characteristics of Darling's Histoplasma capsulatum. Am. J. Trop. Med. 14:93-125.
26. DiSalvo, A. F., A. S. Sekhon, G. A. Land, and W. H. Fleming. 1980. Evaluation of the exoantigen test for identification of Histoplasma species and Coccidioides immitis cultures. J. Clin. Microbiol. 11:238-241.
27. Dismukes, W. E., G. Cloud, C. Bowles, and the NIAID Mycoses Study Group. 1985. Treatment of blastomycosis and histoplasmosis with ketoconazole: results of a prospective randomized clinical trial. Ann. Intern. Med. 103:861-872.
28. Dismukes, W. E., R. W. Bradsher, Jr., G. C. Cloud, C. A. Kauffman, S. W. Chapman, R. B. George, D. A. Stevens, W. M. Girard, M. S. Saag, C. Bowles-Patton, and the NIAID Mycoses Study Group. 1992. Itraconazole therapy for blastomycosis and histoplasmosis. Am. J. Med. 93:489-497.
29. Doyle, T. P., J. E. Loyd, and I. M. Robbins. 2001. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am. J. Respir. Crit. Care Med. 164:657-660.
30. Dupont, B., H. H. C. Brown, K. Westermann, M. D. Martins, J. H. Rex, O. Lortholary, and C. A. Kauffman. 2000. Mycoses in AIDS. Med. Mycol. 38(Suppl. 1):259-268.
31. Durkin, M. M., P. A. Connolly, and L. J. Wheat. 1997. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen. J. Clin. Microbiol. 35:2252-2255.
32. Edwards, L. B., S. A. Acquaviva, V. T. Livesay, F. W. Cross, and C. E. Palmer. 1969. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Annu. Rev. Respir. Dis. 99:1-18.
33. Emmons, C. W. 1949. Isolation of Histoplasma capsulatum from soil. Public Health Rep. 64:892-896.
34. Espinel-Ingroff, A. 1998. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 [L-743,872] and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36:2950-2956.
35. Fosson, A. R., and W. E. Wheeler. 1975. Short-term amphotericin B treatment of severe childhood histoplasmosis. J. Pediatr. 86:32-36.
36. Fowler, V. G., Jr., F. M. Nacinovich, J. A. Alspaugh, and G. R. Corey. 1998. Prosthetic joint infection due to Histoplasma capsulatum: case report and review. Clin. Infect. Dis. 26:1017.
37. Freifeld, A. G., P. C. Iwen, B. L. Lesiak, R. K. Gilroy, R. B. Stevens, and A. C. Kalil. 2005. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl. Infect. Dis. 7:109-115.
38. Friskel, E., S. A. Klotz, W. Bartholomew, and A. Dixon. 2000. Two unusual presentations of urogenital histoplasmosis and a review of the literature. Clin. Infect. Dis. 31:189-191.
39. Furcolow, M. L. 1963. Comparison of treated and untreated severe histoplasmosis. JAMA 183:121-127.
40. Garner, J. A., and D. Kernodle. 1995. False-positive Histoplasma antigen test in a patient with pulmonary blastomycosis. Clin. Infect. Dis. 21:1054.
41. Gaynes, R. P., P. Gardner, and W. Causey. 1981. Prosthetic value endocarditis caused by Histoplasma capsulatum. Arch. Intern. Med. 141:1533-1537.
42. Goldani, L. Z., C. Klock, A. Diehl, A. C. Monteiro, and A. L. Maia. 2000. Histoplasmosis of the thyroid. J. Clin. Microbiol. 38:3890-3891.
43. Goldman, M., R. Zackin, C. J. Fichtenbaum, D. K. Skiest, S. L. Koletar, R. Hafner, L. J. Wheat, P. M. Nyangweso, C. T. Yiannoutsos, C. T. Schnizlein-Bick, S. Owens, J. A. Aberg, and the AIDS Clinical Trial Group AS038 Study Group. 2004. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin. Infect. Dis. 38:1485-1489.
44. Gomez, B. L., J. I. Figueroa, A. J. Hamilton, B. L. Ortiz, M. A. Robledo, A. Restrepo, and R. J. Hay. 1997. Development of a novel antigen detection test for histoplasmosis. J. Clin. Microbiol. 35:2618-2622.
45. Gomez, B. L., J. I. Figueroa, A. J. Hamilton, S. Diez, M. Rojas, A. Tobon, A. Restrepo, and R. J. Hay. 1999. Detection of the 70-kilodalton Histoplasma capsulatum antigen in serum of histoplasmosis patients: correlation between antigenemia and therapy during follow-up. J. Clin. Microbiol. 37:675-680.
46. Gonzalez, G. M., A. W. Fothergill, D. A. Sutton, and M. G. Rinaldi. 2005. In vitro activities of new and established triazoles against opportunistic and dimorphic fungi. Med. Mycol. 43:281-284.
47. Goodwin, R. A., Jr., F. T. Owens, J. D. Snell, W. W. Hubbard, R. D. Buchanan, R. T. Terry, and R. M. des Prez. 1976. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 55:413-452.
48. Goodwin, R. A., Jr., J. A. Nickell, and R. M. des Prez. 1972. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 51:227-246.
49. Goodwin, R. A., Jr., J. E. Loyd, and R. M. des Prez. 1981. Histoplasmosis in normal hosts. Medicine (Baltimore) 60:231-266.
50. Goodwin, R. A., Jr., J. L. Shapiro, G. H. Thurman, S. S. Thurman, and R. M. des Prez. 1980. Disseminated histoplasmosis: clinical and pathological correlations. Medicine (Baltimore) 59:1-33.
51. Gurney, J. W., and D. J. Conces, Jr. 1996. Pulmonary histoplasmosis. Radiology 199:297-306.
52. Gutierrez, M. E., A. Canton, N. Sosa, E. Puga, and L. Talavera. 2005. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin. Infect. Dis. 40:1199-1202.
53. Haynes, R. R., P. A. Connolly, M. M. Durkin, A. M. LeMonte, M. L. Smedema, E. Brizendine, and L. J. Wheat. 2002. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection. J. Infect. Dis. 185:1830-1832.
54. Hofstoffer, R. W., M. Berger, H. T. Clark, and J. Schreiber. 1994. Disseminated Histoplasma capsulatum in a patient with hyper IgM immunodeficiency. Pediatrics 94:234-236.
55. Johns, L. E., R. G. Garrison, and T. G. White. 1973. Bronchopleuralcutaneous fistula due to infection with Histoplasma capsulatum. Chest 63:638-641.
56. Johnson, P. C., L. J. Wheat, G. A. Cloud, M. Goldman, D. Lancaster, D. M. Bamberger, W. G. Powderly, R. Hafner, C. A. Kauffman, W. E. Dismukes, and the NIAID Mycoses Study Group. 2002. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann. Intern. Med. 137:105-109.
57. Johnson, P. C., N. Khardori, A. F. Najjar, F. Butt, P. W. A. Mansell, and G. A. Sarosi. 1988. Progressive disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am. J. Med. 85:152-158.
58. Jones, R. C., and R. A. Goodwin. 1981. Histoplasmosis of bone. Am. J. Med. 70:864-866.
59. Jones, T. F., G. L. Swinger, A. S. Craig, M. M. McNeil, L. Kaufman, and W. Schaffner. 1999. Acute pulmonary histoplasmosis in bridge workers: a persistent problem. Am. J. Med. 106:480-482.
60. Judson, M. A. 2004. Noninvasive Aspergillus pulmonary disease. Semin. Respir. Crit. Care Med. 25:203-219.
61. Kanawaty, D. S., M. J. B. Stalker, and P. W. Munt. 1991. Nonsurgical treatment of Histoplasma endocarditis involving a bioprosthetic valve. Chest 99:253-256.
62. Kataria, Y. P., P. B. Campbell, and B. T. Burlingham. 1981. Acute pulmonary histoplasmosis presenting as adult respiratory distress syndrome: Effect of therapy on clinical and laboratory features. South. Med. J. 74:534-537.
63. Kauffman, C. A. 2003. Histoplasmosis, p. 285-298. In W. E. Dismukes, P. G. Pappas, and J. D. Sobel (ed.), Clinical mycology. Oxford University Press, New York, NY.
64. Kauffman, C. A., K. S. Israel, J. W. Smith, A. C. White, J. Schwarz, and G. F. Brooks. 1978. Histoplasmosis in immunosuppressed patients. Am. J. Med. 64:923-932.
65. Kauffman, C. A., T. G. Slama, and L. J. Wheat. 1981. Histoplasma capsulatum epididymitis. J. Urol. 125:434-435.
66. Kaufman, L., and P. Standard. 1978. Improved version of the exoantigen test for identification of Coccidioides immitis and Histoplasma capsulatum cultures. J. Clin. Microbiol. 8:42-45.
67. Kilburn, C. D., and D. S. McKinsey. 1991. Recurrent massive pleural effusion due to pleural, pericardial, and epicardial fibrosis in histoplasmosis. Chest 100:1715-1717.
68. Kirn, D. H., D. Fredericks, J. A. McCutchan, D. Stites, and M. Shuman. 1995. Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis. Clin. Infect. Dis. 21:1048-1049.
69. Kleger, B., and L. Kaufman. 1973. Detection and identification of diagnostic Histoplasma capsulatum precipitates by counterelectrophoresis. Appl. Microbiol. 26:231-238.
70. Klein, C. J., R. P. Dinapoli, Z. Temesgen, and F. B. Meyer. 1999. Central nervous system histoplasmosis mimicking a brain tumor: difficulties in diagnosis and treatment. Mayo Clin. Proc. 74:803-807.
71. Knapp, S., M. Turnherr, G. Dekan, B. Willinger, G. Stingl, and A. Rieger. 1999. A case of HIV-associated histoplasmosis successfully treated with fluconazole. Eur. J. Clin. Microbiol. Infect. Dis. 18:658-661.
72. Koduri, P. R., V. Chindi, P. DeMarais, B. A. Mizock, A. R. Patel, and R. A. Weinstein. 1995. Reactive hemophagocytic syndrome: a new presentation of disseminated histoplasmosis in patients with AIDS. Clin. Infect. Dis. 21:1463-1465.
73. Kohler, S., L. J. Wheat, P. Connolly, C. Schnizlein-Bick, M. Durkin, M. Smedema, J. Goldberg, and E. Brizendine. 2000. Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model. Antimicrob. Agents Chemother. 44:1850-1854.
74. Lamps, L. W., C. P. Molina, A. B. West, R. C. Haggit, and M. A. Scott. 2000. The pathological spectrum of gastrointestinal and hepatic histoplasmosis. Am. J. Clin. Pathol. 113:64-72.
75. LeMonte, A., K. Washum, M. Smedema, C. Schnizlein-Bick, R. Kohler, and L. J. Wheat. 2000. Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis. J. Infect. Dis. 182:545-550.
76. Li, R. K., M. A. Ciblak, N. Nordoff, L. Pasarell, D. W. Warnock, and M. R. McGinnis. 2000. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob. Agents Chemother. 44:1734-1736.
77. Lottenberg, O., R. H. Waldman, L. Ajello, G. L. Hoff, W. Bigler, and S. R. Zellner. 1979. Pulmonary histoplasmosis associated with exploration of a bat cave. Am. J. Epidemiol. 110:156-161.
78. Loyd, J. E., B. F. Tillman, J. B. Atkinson, and R. M. des Prez. 1988. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) 67:295-310.
79. Maholtz, M. S., J. H. Dauber, and S. A. Yousem. 1994. Fluconazole therapy in Histoplasma mediastinal granuloma. Am. J. Med. Sci. 307:274-277.
80. Mandell, W., D. M. Goldberg, and H. C. Neu. 1986. Histoplasmosis in patients with the acquired immune deficiency syndrome. Am. J. Med. 81:974-978.
81. Martagon-Villamil, J., N. Shrestha, M. Sholtis, C. M. Isada, G. S. Hall, T. Byrne, B. A. Lodge, L. B. Reller, and G. W. Procop. 2003. Identification of Histoplasma capsulatum from culture extracts by real-time PCR. J. Clin. Microbiol. 41:1295-1298.
82. Mathisen, D. J., and H. C. Grillo. 1992. Clinical manifestations of mediastinal fibrosis and histoplasmosis. Ann. Thorac. Surg. 54:1053-1058.
83. Matthay, R. A., D. C. Levin, A. B. Wicks, and J. H. Ellis, Jr. 1976. Disseminated histoplasmosis involving an aortofemoral graft. JAMA 235:1478-1479.
84. Mawhorter, S. D., G. V. Curley, E. D. Kursh, and C. E. Farver. 2000. Prostatic and central nervous system histoplasmosis in an immunocompetent host: case report and review of the prostatic histoplasmosis literature. Clin. Infect. Dis. 30:595-598.
85. McKinsey, D. S., C. A. Kauffman, P. G. Pappas, G. A. Cloud, W. M. Girard, P. K. Sharkey, R. J. Hamill, C. J. Thomas, W. E. Dismukes, and the NIAID Mycoses Study Group. 1996. Fluconazole therapy for histoplasmosis. Clin. Infect. Dis. 23:996-1001.
86. McKinsey, D. S., L. J. Wheat, G. A. Cloud, M. Pierce, J. R. Black, D. M. Bamberger, M. Goldman, C. J. Thomas, H. M. Gutsch, B. Moskovitz, W. E. Dismukes, C. A. Kauffman, and the NIAID Mycoses Study Group. 1999. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. Clin. Infect. Dis. 28:1049-1056.
87. McKinsey, D. S., R. A. Spiegel, L. Hutwanger, J. Stanford, M. R. Driks, J. Brewer, M. R. Gupta, D. L. Smith, M. C. O'Connor, and L. Dall. 1997. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin. Infect. Dis. 24:1195-1203.
88. Medeiros, A. A., S. D. Marty, F. E. Tosh, and T. D. Y. Chin. 1966. Erythema nodosum and erythema multiforme as clinical manifestations of histoplasmosis in a community outbreak. N. Engl. J. Med. 274:415-420.
89. Mignogna, M. D., S. Fedele, L. Lo Russo, E. Ruoppo, and L. Lo Muzio. 2001. A case of oral localized histoplasmosis in an immunocompetent patient. J. Clin. Microbiol. Infect. Dis. 20:753-755.
90. Murray, J. J., and C. R. Heim. 1985. Hypercalcemia in disseminated histoplasmosis, aggravation by vitamin D. Am. J. Med. 78:881-884.
91. Newman, S. L. 2001. Cell-mediated immunity to Histoplasma capsulatum. Semin. Respir. Infect. 16:102-108.
92. Odio, C. M., M. Navarrete, J. M. Carrillo, L. Mora, and A. Carranza. 1999. Disseminated histoplasmosis. Pediatr. Infect. Dis. J. 18:1065-1068.
93. Orchard, J. L., F. Luparello, and D. Brunskill. 1979. Malabsorption syndrome occurring in the course of disseminated histoplasmosis. Am. J. Med. 66:331-336.
94. Ozols, I. I., and L. J. Wheat. 1981. Erythema nodosum in an epidemic of histoplasmosis in Indianapolis, Indiana. Arch. Dermatol. 117:709-712.
95. Palmer, C. E. 1945. Non-tuberculous pulmonary calcification and sensitivity to histoplasmin. Public Health Rep. 60:513-520.
96. Parker, J. D., G. A. Sarosi, I. L. Doto, R. E. Bailey, and F. E. Tosh. 1970. Treatment of chronic pulmonary histoplasmosis. N. Engl. J. Med. 283:225-229.
97. Parsons, R. J., and C. J. D. Zarafonetis. 1945. Histoplasmosis in man, report of seven cases and a review of seventy-one cases. Arch. Intern. Med. 75:1-23.
98. Paya, C. V., G. D. Roberts, and F. R. Cockerill III. 1987. Laboratory methods for the diagnosis of disseminated histoplasmosis: clinical importance of the lysis-centrifugation blood culture technique. Mayo Clin. Proc. 62:480-485.
99. Paya, C. V., G. D. Roberts, and F. R. Cockerill III. 1987. Transient fungemia in acute pulmonary histoplasmosis: detection by new blood-culturing techniques. J. Infect. Dis. 156:313-315.
100. Perfect, J. R., K. A. Marr, T. J. Walsh, R. N. Greenberg, B. Dupont, J. de la Torre-Cisneros, G. Just-Nubling, H. T. Schlamm, I. Lutsar, A. Espinel-Ingroff, and E. Johnson. 2003. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:1122-1131.
101. Picardi, J. L., C. A. Kauffman, J. Schwarz, J. C. Holmes, J. P. Phair, and N. O. Fowler. 1976. Pericarditis caused by Histoplasma capsulatum. Am. J. Cardiol. 37:82-88.
102. Picardi, J. L., C. A. Kauffman, J. Schwarz, and J. P. Phair. 1976. Detection of precipitating antibodies to Histoplasma capsulatum by counterimmunoelectrophoresis. Am. Rev. Respir. Dis. 114:171-176.
103. Pitisuttithum, P., R. Negroni, J. R. Graybill, B. Bustamante, P. Pappas, S. Chapman, R. S. Hare, and C. J. Hardalo. 2005. Activity of posaconazole in the treatment of central nervous system fungal infections. J. Antimicrob. Chemother. 56:745-755.
104. Reddy, P., D. F. Gorelick, C. A. Brasher, and H. Larsh. 1970. Progressive disseminated histoplasmosis as seen in adults. Am. J. Med. 48:629-636.
105. Restrepo, A., B. Clark, D. R. Graham, S. Greene, R. Hare, G. Corcoran, C. Hardalo, T. Moore, R. Negroni, and J. Graybill. 7 July 2006, posting date. Salvage treatment of histoplasmosis with posaconazole. J. Infect. doi: 10.1016/j.jinf.2006.05.006.
106. Rickets, V., R. Bialek, K. Tintlenot, V. Jacobi, and G. Just-Nubling. 2002. Rapid PCR-based diagnosis of disseminated histoplasmosis in an AIDS patient. Eur. J. Clin. Microbiol. Infect. Dis. 21:821-823.
107. Rivera, I., R. Curless, F. Indacochea, and G. Scott. 1992. Chronic progressive CNS histoplasmosis presenting in childhood: response to fluconazole therapy. Pediatr. Neurol. 8:151-153.
108. Rogers, E. W., A. E. Weyman, R. J. Noble, and S. C. Bruins. 1978. Left atrial myxoma infected with Histoplasma capsulatum. Am. J. Med. 64:683-690.
109. Rosenthal, J., K. D. Brandt, L. J. Wheat, and T. G. Slama. 1983. Rheumatologic manifestations of histoplasmosis in the recent Indianapolis epidemic. Arthritis Rheum. 26:1065-1070.
110. Saidinejad, M., M. M. Burns, and M. B. Harper. 2004. Disseminated histoplasmosis in a nonendemic area. Pediatr. Infect. Dis. J. 23:781-782.
111. Sarosi, G. A., D. W. Voth, B. A. Dahl, I. L. Doto, and F. E. Tosh. 1971. Disseminated histoplasmosis: results of long-term follow-up. Ann. Intern. Med. 75:511-516.
112. Schub, H. M., C. G. Spivey, and G. D. Baird. 1966. Pleural involvement in histoplasmosis. Am. Rev. Respir. Dis. 94:225-232.
113. Schuster, T. G., B. K. Hollenbeck, C. A. Kauffman, S. W. Chensue, and J. T. Wei. 2000. Testicular histoplasmosis. J. Urol. 164:1652.
114. Schwarz, J. 1981. Histoplasmosis. Praeger Publishers, New York, NY.
115. Schwarz, J., M. D. Schaen, and J. L. Picardi. 1976. Complications of the arrested primary histoplasmic complex. JAMA 236:1157-1161.
116. Sellers, T. F., W. N. Price, and W. M. Newberry. 1965. An epidemic of erythema multiforme and erythema nodosum caused by histoplasmosis. Ann. Intern. Med. 62:1244-1262.
117. Sharkey-Mathis, P. K., J. Velez, R. Fetchick, and J. R. Graybill. 1993. Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole. J. Acquir. Immune Defic. Syndr. 6:809-819.
118. Sherrick, A. D., L. R. Brown, G. F. Harms, and J. L. Myers. 1994. The radiographic findings of fibrosing mediastinitis. Chest 106:484-489.
119. Smith, C. D., and N. L. Goodman. 1975. Improved culture method for the isolation of Histoplasma capsulatum and Blastomyces dermatitidis from contaminated specimens. Am. J. Clin. Pathol. 63:276-280.
120. Smith, J. W., and J. P. Utz. 1972. Progressive disseminated histoplasmosis, a prospective study of 26 patients. Ann. Intern. Med. 76:557-565.
121. Stockman, L., K. A. Clark, J. M. Hunt, and G. D. Roberts. 1993. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J. Clin. Microbiol. 31:845-850.
122. Strayer, D. S., M. B. Gutwein, D. Herbold, and R. Bresalier. 1981. Histoplasmosis presenting as the carpal tunnel syndrome. Am. J. Surg. 141:286-288.
123. Suh, K. N., T. Anekthananon, and P. R. Mariuz. 2001. Gastrointestinal histoplasmosis in patients with AIDS: case report and review. 32:483-491.
124. Sutliff, W. D., C. E. Andrews, E. Jones, R. T. Terry, et al. 1964. Histoplasmosis cooperative study. Am. Rev. Respir. Dis. 89:641-650.
125. Sweet, G. H., R. S. Cimprich, A. C. Cook, and D. E. Sweet. 1979. Antibodies in histoplasmosis detected by use of yeast and mycelial antigens in immunodiffusion and electroimmunodiffusion. Am. Rev. Respir. Dis. 120:441-448.
126. Thornberry, D. K., L. J. Wheat, K. Brandt, and J. Rosenthal. 1982. Histoplasmosis presenting with joint pain and hilar adenopathy: "pseudosarcoidosis." Arthritis Rheum. 25:1396-1402.
127. Tiraboschi, I., I. Casas Parera, R. Pikielny, G. Scattini, and F. Micheli. 1992. Chronic Histoplasma capsulatum infection of the central nervous system successfully treated with fluconazole. Eur. Neurol. 32:70-73.
128. Torres, H. A., R. Y. Hachem, R. F. Chemaly, D. P. Kontoyiannis, and I. I. Raad. 2005. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect. Dis. 5:775-785.
129. Wheat, J., M. French, B. Batteiger, and R. Kohler. 1985. Cerebrospinal fluid Histoplasma antibodies in central nervous system histoplasmosis. Arch. Intern. Med. 145:1237-1240.
130. Wheat, J., R. Hafner, M. Wulfson, P. Spencer, K. Squires, W. Powderly, B. Wong, M. Rinaldi, M. Saag, R. Hamill, R. Murphy, P. Connolly-Stringfield, N. Briggs, S. Owens, et al. 1993. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 118:610-616.
131. Wheat, J., R. Hafner, A. H. Korzun, M. T. Limjoco, P. Spencer, R. A. Larsen, G. F. M. Hecht, W. Powderly, and the AIDS Clinical Trial Group. 1995. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am. J. Med. 98:336-342.
132. Wheat, J. 1997. Histoplasmosis: experience during outbreaks in Indianapolis and review of the literature. Medicine (Baltimore) 76:339-354.
133. Wheat, J. S. MaWhinney, R. Hafner, D. McKinsey, D. Chen, A. Korzun, K. Skahan, P. Johnson, R. Hamill, D. Bamberger, P. Pappas, J. Stansell, S. Koletar, K. Squires, R. A. Larsen, T. Cheung, N. Hyslop, K. K. Lai, D. Schneider, C. Kauffman, M. Saag, W. Dismukes, W. Powderly, et al. 1997. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am. J. Med. 103:223-232.
134. Wheat, J., H. Wheat, P. Connolly, M. Kleiman, K. Supparatpinyo, K. Nelson, R. Bradsher, and A. Restrepo. 1997. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin. Infect. Dis. 24:1169-1171.
135. Wheat, J., P. Marichal, H. Vanden Bossche, A. Le Monte, and P. Connolly. 1997. Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum. Antimicrob. Agents Chemother. 41:410-414.
136. Wheat, J., G. Sarosi, D. McKinsey, R. Hamill, R. Bradsher, P. Johnson, J. Loyd, and C. A. Kauffman. 2000. Practice guidelines for the management of patients with histoplasmosis. Clin. Infect. Dis. 30:688-695.
137. Wheat, L. J., T. G. Slama, H. E. Eitzen, R. B. Kohler, M. L. V. French, and J. L. Biesecker. 1981. A large urban outbreak of histoplasmosis: clinical features. Ann. Intern. Med. 94:331-337.
138. Wheat, L. J., L. Stein, B. C. Corya, J. L. Wass, J. A. Norton, K. Grider, T. G. Slama, M. L. French, and R. B. Kohler. 1983. Pericarditis as a manifestation of histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 62:110-119.
139. Wheat, L. J., R. B. Kohler, M. L. V. French, M. Garten, M. Kleiman, S. E. Zimmerman, W. Schlech, J. Ho, A. C. White, and Z. Brahmi. 1983. Immunoglobulin M and G histoplasmal antibody response in histoplasmosis. Am. Rev. Respir. Dis. 128:65-70.
140. Wheat, L. J., E. J. Sith, and B. Sathapatayavongs. 1983. Histoplasmosis in renal allograft recipients: two large urban outbreaks. Arch. Intern. Med. 143:703-707.
141. Wheat, L. J., J. Wass, J. Norton, R. B. Kohler, M. L. V. French, and J. L. Biesecker. 1984. Cavitary histoplasmosis occurring during two large urban outbreaks: analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore) 63:201-209.
142. Wheat, L. J., M. L. V. French, S. Kamel, and R. P. Tewari. 1986. Evaluation of cross-reactions in Histoplasma capsulatum serologic tests. J. Clin. Microbiol. 23:493-499.
143. Wheat, L. J., R. B. Kohler, and R. P. Tewari. 1986. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N. Engl. J. Med. 314:83-88.
144. Wheat, L. J., R. B. Kohler, R. P. Tewari, M. Garten, and M. L. V. French. 1989. Significance of Histoplasma antigen in the cerebrospinal fluid of patients with meningitis. Arch. Intern. Med. 149:302-304.
145. Wheat, L. J., M. L. V. French, and J. L. Wass. 1989. Sarcoidlike manifestations of histoplasmosis. Arch. Intern. Med. 149:2421-2426.
146. Wheat, L. J., B. E. Batteiger, and B. Sathapatayavongs. 1990. Histoplasma capsulatum infections of the central nervous system: a clinical review. Medicine (Baltimore) 69:244-260.
147. Wheat, L. J., P. A. Connolly-Stringfield, R. L. Baker, M. F. Curfman, M. E. Eads, K. S. Israel, S. A. Norris, D. H. Webb, and M. L. Zeckel. 1990. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 69:361-374.
148. Wheat, L. J., P. Connolly-Stringfield, R. Blair, K. Connolly, T. Garringer, and B. P. Katz. 1991. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann. Intern. Med. 115:936-941.
149. Wheat, L. J., P. Connolly-Stringfield, R. Blair, K. Connolly, T. Garringer, B. P. Katz, and M. Gupta. 1992. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am. J. Med. 92:153-160.
150. Wheat, L. J., P. Connolly-Stringfield, B. Williams, K. Connolly, R. Blair, M. Bartlett, and M. Durkin. 1992. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am. Rev. Respir. Dis. 145:1421-1424.
151. Wheat, L. J., G. Cloud, P. C. Johnson, P. Connolly, M. Goldman, A. Le Monte, D. E. Fuller, T. E. Davis, R. Hafner, the AIDS Clinical Trials Group, and the Mycoses Study Group of NIAID. 2001. Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrob. Agents Chemother. 45:2354-2357.
152. Wheat, L. J. 2001. Laboratory diagnosis of histoplasmosis: update 2000. Semin. Respir. Infect. 16:131-140.
153. Wheat, L. J., P. Connolly, N. Haddad, A. Le Monte, E. Brizendine, and R. Hafner. 2002. Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS. Antimicrob. Agents Chemother. 46:248-250.
154. Wheat, L. J., T. Garringer, E. Brizendine, and P. Connolly. 2002. Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Diagn. Microbiol. Infect. Dis. 43:29-37.
155. Wheat, L. J., and C. A. Kauffman. 2003. Histoplasmosis. Infect. Dis. Clin. N. Am. 17:1-19.
156. Wheat, L. J., P. Connolly, M. Durkin, B. K. Book, A. J. Tector, J. Fridell, and M. D. Pescovitz. 2004. False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies. Transpl. Infect. Dis. 6:23-27.
157. Wheat, L. J., D. Conces, S. D. Allen, D. Blue-Hnidy, and J. Loyd. 2004. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin. Respir. Crit. Care Med. 25:129-144.
158. Wheat, L. J., C. E. Musial, and E. Jenny-Avital. 2005. Diagnosis and management of central nervous system histoplasmosis. Clin. Infect. Dis. 40:844-852.
159. Whitt, S. P., G. A. Koch, B. Fender, N. Ratnasamy, and D. Everett. 2004. Histoplasmosis in pregnancy. Case series and report of transplacental transmission. Arch. Intern. Med. 164:454-458.
160. Williams, B. M., P. Fojtasek, P. Connolly-Stringfield, and L. J. Wheat. 1994. Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind. Arch. Pathol. Lab. Med. 118:1205-1208.
161. Wilson, D. A., H. G. Muchmore, R. G. Tisda, A. Fahmy, and J. V. Pitha. 1984. Histoplasmosis of the adrenal glands studied by CT. Radiology 150:779-783.
162. Wilson, M. L., T. E. Davis, S. Mirrett, J. Reynolds, D. Fuller, S. D. Allen, K. K. Flint, F. Koontz, and L. B. Reller. 1993. Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia. J. Clin. Microbiol. 31:865-871.
163. Wood, K. L., C. A. Hage, K. S. Knox, M. B. Kleiman, A. Sannuti, R. B. Day, L. J. Wheat, and H. L. Twigg III. 2003. Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am. J. Respir. Crit. Care Med. 167:1279-1282.
164. Woods, J. P., E. L. Heinecke, J. W. Luecke, E. Malsonado, J. Z. Ng, D. M. Retallack, and M. M. Timmerman. 2001. Pathogenesis of Histoplasma capsulatum. Semin. Respir. Infect. 16:91-101.
165. Wynne, J. W., and G. N. Olsen. 1974. Acute histoplasmosis presenting as the adult respiratory distress syndrome. Chest 66:158-161.
166. Yan, T. D., M. S. Kavuru, B. Yen-Lieberman, A. Brzezinski, and S. M. Gordon. 2005. Immune function evaluation (ImmunoKnow assay) in a patient treated with infliximab who developed miliary histoplasmosis. Infect. Dis. Clin. Pract. 13:315-317.
167. Yaseen, Z., D. Havlichek, B. Mathes, and M.-H. Hahn. 1997.
168. Young, E. J., B. Vainrub, and D. M. Musher. 1978. Pericarditis due to histoplasmosis. JAMA 240:1750-1751.
169. Zerbe, C. S., and S. M. Holland. 2005. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin. Infect. Dis. 41:e38-e41.